Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein

青光眼视神经乳头突触核蛋白病及γ-突触核蛋白的功能

基本信息

项目摘要

DESCRIPTION (provided by applicant): The broad long-term goal of this application is to uncover the mechanism of retinal ganglion cell (RGC) degeneration in glaucoma so as to be able to design rational therapeutic interventions based on neuroprotection. Based on recent data showing that glaucoma animal models develop aggregates of ?-synuclein in the retina and optic nerve similar to the aggregates composed of a-synuclein in Parkinson's disease and animal models, it appears likely the glaucoma and Parkinson's disease share many pathogenic mechanisms. The proposed studies aim to understand the nature and significance of the ?-synuclein aggregates in glaucoma animal models. There are two processes that appear to correlate with the development of the ?-synuclein aggregates in mice that undergo glaucoma-like changes. First, despite ?-synuclein being expressed normally only in RGC, in glaucoma animal models there are a newly-identified subset of astrocytes within the optic nerve head that contain ?-synuclein aggregates and upregulate a pathway that is linked to phagocytosis. Second, the ?-synuclein aggregates are found associated with a lipid organelle, the lipid droplet, and there is a large increase in these lipid droplets in the glaucoma animal models. The proposed experiment aim to determine whether there is a cause and effect relationship between the ?-synuclein aggregates and these two associated phenomena. Independently, they will test whether these associated phenomena have any relevance to glaucoma progression. Finally, since animal models do not always reflect changes in human diseases, key findings made in these animal models regarding ?-synuclein aggregates, astrocyte phagocytosis, and lipid droplet formation, will be examined in the retinas and optic nerves of verified glaucoma patients. It is likely that the proposed studies will shed much light onto how synucleins function in health and disease. Importantly, in identifying a key pathological mechanism in glaucoma that is so similar to those seen in other common neurodegenerative disorders, the proposed studies may revolutionize how glaucoma is studied and, in the future, treated.
描述(由申请人提供):本申请的广泛长期目标是揭示青光眼中视网膜神经节细胞(RGC)变性的机制,以便能够设计基于神经保护的合理治疗干预措施。基于最近的数据显示青光眼动物模型产生了?-聚集体视网膜和视神经中的突触核蛋白类似于帕金森病和动物模型中由α-突触核蛋白组成的聚集体,这似乎可能是青光眼和帕金森病共享许多致病机制。拟议的研究旨在了解的性质和意义?-青光眼动物模型中的突触核蛋白聚集体。有两个过程似乎与?突触核蛋白聚集在小鼠中,经历类似于肉瘤的变化。首先,尽管?突触核蛋白仅在RGC中正常表达,在青光眼动物模型中,在视神经乳头内有一个新鉴定的星形胶质细胞亚群,其含有?突触核蛋白聚集并上调与吞噬作用相关的途径。第二,?发现突触核蛋白聚集体与脂质细胞器(脂滴)相关,并且在青光眼动物模型中这些脂滴大量增加。实验的目的是确定是否有一个因果关系?突触核蛋白聚集体和这两种相关现象。独立地,他们将测试这些相关现象是否与青光眼进展有关。最后,由于动物模型并不总是反映人类疾病的变化,在这些动物模型中的关键发现,将在经证实的青光眼患者的视网膜和视神经中检查突触核蛋白聚集体、星形胶质细胞吞噬作用和脂滴形成。这些研究很可能会揭示突触核蛋白在健康和疾病中的作用。重要的是,在确定青光眼的关键病理机制,这是如此类似于在其他常见的神经退行性疾病中看到的,拟议的研究可能会彻底改变如何青光眼的研究,并在未来,治疗。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Translational profiling of retinal ganglion cell optic nerve regeneration in Xenopus laevis.
  • DOI:
    10.1016/j.ydbio.2016.06.003
  • 发表时间:
    2017-06-15
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Whitworth GB;Misaghi BC;Rosenthal DM;Mills EA;Heinen DJ;Watson AH;Ives CW;Ali SH;Bezold K;Marsh-Armstrong N;Watson FL
  • 通讯作者:
    Watson FL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NICHOLAS R MARSH-ARMSTRONG其他文献

NICHOLAS R MARSH-ARMSTRONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NICHOLAS R MARSH-ARMSTRONG', 18)}}的其他基金

Optic nerve head glymphatics and debris clearance in glaucoma
青光眼中的视神经乳头淋巴管和碎片清除
  • 批准号:
    10200062
  • 财政年份:
    2018
  • 资助金额:
    $ 38.38万
  • 项目类别:
Optic nerve head glymphatics and debris clearance in glaucoma
青光眼中的视神经乳头淋巴管和碎片清除
  • 批准号:
    10455455
  • 财政年份:
    2018
  • 资助金额:
    $ 38.38万
  • 项目类别:
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells
轴突线粒体降解是视网膜神经节细胞的致命弱点
  • 批准号:
    9899992
  • 财政年份:
    2016
  • 资助金额:
    $ 38.38万
  • 项目类别:
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells
轴突线粒体降解是视网膜神经节细胞的致命弱点
  • 批准号:
    9198767
  • 财政年份:
    2016
  • 资助金额:
    $ 38.38万
  • 项目类别:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
青光眼视神经乳头突触核蛋白病及γ-突触核蛋白的功能
  • 批准号:
    8042280
  • 财政年份:
    2011
  • 资助金额:
    $ 38.38万
  • 项目类别:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
青光眼视神经乳头突触核蛋白病及γ-突触核蛋白的功能
  • 批准号:
    8298971
  • 财政年份:
    2011
  • 资助金额:
    $ 38.38万
  • 项目类别:
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA
伽玛突触核蛋白聚集体和青光眼
  • 批准号:
    8361930
  • 财政年份:
    2011
  • 资助金额:
    $ 38.38万
  • 项目类别:
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA
伽玛突触核蛋白聚集体和青光眼
  • 批准号:
    8169646
  • 财政年份:
    2010
  • 资助金额:
    $ 38.38万
  • 项目类别:
Role of a Novel Corepressor in Nuclear Receptor Action
新型辅阻遏物在核受体作用中的作用
  • 批准号:
    7217882
  • 财政年份:
    2006
  • 资助金额:
    $ 38.38万
  • 项目类别:
Role of a Novel Corepressor in Nuclear Receptor Action
新型辅阻遏物在核受体作用中的作用
  • 批准号:
    7369766
  • 财政年份:
    2006
  • 资助金额:
    $ 38.38万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 38.38万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了